This is the story of Dr. John B. Simpson, health and medical innovator, who is also living with multiple sclerosis. Dr. Simpson talks about the importance of collaborative research to develop the next generation of MS therapeutics, and explains why he is a supporter of the Myelin Repair Foundation.
John B. Simpson, MD, PhD Founder, Chief Executive Officer, and Board Member, Avinger, Inc.
Dr. Simpson has a unique ability to recognize unmet clinical needs, generate concepts to address these needs, and transform these concepts into clinically and commercially relevant products. Dr. Simpson has started several companies dedicated to providing patients with the most cutting-edge therapies in a variety of different areas, including directional atherectomy (coronary and peripheral), chronic total occlusions (CTOs), ultrasound, percutaneous transluminal coronary angioplasty, suture-mediated vascular closure, and local drug delivery.
His companies have sold for +$1.7 billion in aggregate, and include Advanced Cardiovascular Systems (sold to Eli Lilly in 1981), Devices for Vascular Intervention (acquired by Eli Lilly in 1990), Perclose (purchased by Abbott in 1999), and FoxHollow Technologies (merged with ev3 in 2007).
Thomas J. Fogarty, MD Chairman, Director, Founder of the Fogarty Institute of Innovation
An internationally recognized cardiovascular surgeon, inventor and entrepreneur, Dr. Fogarty has served as a founder, chairman or board member of over 30 business and research companies. During the past forty years, he has acquired 135 surgical patents, including the "industry standard" Fogarty balloon catheter and the widely used Aneurx Stent Graft that replaces open surgery aortic aneurysm. He is the recipient of countless awards and honors, including the Jacobson Innovation Award of the American College of Surgeons and the 2000 Lemelson-MIT prize for Invention and Innovation. Dr. Fogarty was inducted into the Inventors Hall of Fame in December 2001.
Larry Sonsini Chairman of Wilson Sonsini Goodrich & Rosati
Chairman of Wilson Sonsini Goodrich & Rosati, Larry W. Sonsini has gained international recognition for his expertise in the areas of corporate law, corporate governance, securities, and mergers and acquisitions. He has been instrumental in many of the most notable IPOs, mergers, acquisitions, and other key transactions of Silicon Valley and beyond.
Scott Johnson President, CEO and Founder, Myelin Repair Foundation
Scott Johnson, who has been living with multiple sclerosis for over 35 years, is using his acumen as a business consultant and Silicon Valley entrepreneur to reform a system for medical research and drug development that has failed to produce new patient treatments for millions living with chronic and debilitating diseases.
Scott's ideas have been recognized by the Wall Street Journal, Forbes, New York Times, Fast Company, The Atlantic, Newsweek, BusinessWeek and more. In 2006, he was named as one of Scientific American's top 50 worldwide for business, science and policy leadership. In addition, Scott was recognized as the Northern California Ernst & Young Entrepreneur Of The Year® in the Social Entrepreneurship category in 2010 and received Research!America's 2012 Gordon and Llura Gund Leadership Award. ______________________________________________